Stay updated on CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome
Sign up to get notified when there's something new on the CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome page.

Latest updates to the CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe history now includes a new Revision: v3.5.4 entry, replacing the previous v3.5.3. This update signals a refreshed page version in the record history for the study record.SummaryDifference0.1%

- Check20 days agoChange DetectedThe References section was removed from the study record view, removing bibliographic citations from this page.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedUpdated the page’s software/footer revision indicator from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check41 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the study record history.SummaryDifference0.1%

- Check70 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the Record History section.SummaryDifference0.1%

- Check77 days agoChange DetectedA new revision entry v3.4.3 was added and the previous revision v3.4.2 removed.SummaryDifference0.1%

Stay in the know with updates to CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome
Enter your email address, and we'll notify you when there's something new on the CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome page.